Stem cells are immature cells that grow into the specialised cells that comprise the body`s tissue. The aim is to coax these cells into becoming nerve cells to replenish those damaged in spinal injury.
Doctors at Loyola University Medical Center in Illinois, have used a new high-tech catheter device that can improve outcomes of patients treated for atrial fibrillation, the most common irregular heartbeat.
India today raised serious concerns over the USFDA`s audit inspections of Indian pharma companies and `disproportionate penalties` in some instances and said it would submit a discussion document on the issues to the US.
The suspect is dead, the fertility clinic where he reportedly replaced a customer`s sperm with his own no longer operates, and the clinic left no records that might show the extent of the scandal, the University of Utah said today.
India`s drug major Ranbaxy Laboratories used "fraudulent" data to get USFDA nod to sell its generic drugs, according to whistleblower Dinesh Thakur, who has also accused the drug-maker of faking test results.
Hit by the new drug pricing policy and regulatory interventions, growth rate of the Rs 72,069-crore Indian pharmaceutical market has slowed down to 9.8 per cent in 2013 as compared to 16.6 per cent in 2012.
Drug firm Jubilant Life Sciences Ltd Friday said it has received approval from the US Food and Drugs Administration (USFDA) to market generic versions of GlaxoSmithKline`s anti-depressant Wellbutrin SR and smoking cessation aid, Zyban.
Tablets embedded with `black fibre` that was suspected to be hair from an employee`s arm, `black spots` of oil from machines in tablets and absence of running water in toilets were some observations made by USFDA that has banned import of drugs made at Ranbaxy`s Mohali unit.
Pharma major Lupin Limited Friday announced that its US-based subsidiary Lupin Pharmaceuticals, Inc has got approval from the US health regulator to sell a generic version of Sanofi Aventis’ Rifadin capsules, used to treat tuberculosis, in the American market.
Novartis said on Tuesday U.S. regulators have granted breakthrough therapy status for its investigational compound bimagrumab for the potential treatment of patients with sporadic inclusion body myositis (sIBM).
Glenmark Pharmaceuticals today said it has received US health regulator`s approval to market generic version of Forest Laboratories` Campral Delayed Release Tablets, a drug used for alcohol abstinence, in the American market.